CompletedEarly Phase 1ketamine

S-ketamin Premedication in Pediatric EENT Surgery

Sponsored by Eye & ENT Hospital of Fudan University

NCT ID
NCT04757675
Target Enrollment
320 participants
Start Date
2021-03-01
Est. Completion
2022-01-01

About This Study

We aim to investigate the effects of premedication (intranasal or intravenous administration) of s-ketamin, dexmedetomidine, and combination for premedication in children undergoing ENT surgery.

Conditions Studied

EmotionsSeparation AnxietyPain, Procedural

Interventions

  • •S-ketamine 0.3
  • •S-ketamine 0.5
  • •S-ketamine 2
  • •S-ketamine 1+Dexmedetomidine 1
  • •S-ketamine 0.5 +Dexmedetomidine 2

Eligibility

Age:2 Years - 12 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* After obtaining the informed consent from their parents or proxies, the children aged 2 to 12 years, scheduled for elective ENT surgery, of American Society of Anesthesiologists (ASA) I or II were enrolled in this study.

Exclusion Criteria:

* Congenital heart diseases, congenital dysplasia, obstructive sleep apnea syndrome, upper respiratory tract infection, body mass index (BMI) ≥25, allergy to S-ketamin or dexmedetomidine, and severe liver or kidney disease.

Study Locations (1)

Eye and ENT Hospital of Fudan University
Shanghai, China

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

S-ketamin Premedication in Pediatric EENT Surgery | Huxley